Aktis Oncology, Inc. (AKTS) on GreekSoup https://greeksoup.ai/stocks/us/akts/ Every dated entry in the public record on Aktis Oncology, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Sat, 31 Oct 2026 00:00:00 +0000 Aktis Oncology, Inc.: short interest 4,313,744 shares at the 15 October 2026 settlement, 11.27 days to coverhttps://greeksoup.ai/stocks/us/akts/short-interest/us:AKTS:short-interest:2026-10-15:f3bffd086fThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Aktis Oncology, Inc.: short interest 4,715,294 shares at the 30 September 2026 settlement, 7.30 days to coverhttps://greeksoup.ai/stocks/us/akts/short-interest/us:AKTS:short-interest:2026-09-30:a29d6ccb60Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Aktis Oncology, Inc.: Czibere Akos (Chief Medical Officer) sold 5,099 shares (under a trading plan set in advance) at $20.19 on 23 September 2026, $102,973https://greeksoup.ai/stocks/us/akts/insiders/us:AKTS:insider:2026-09-24:67e4fe8520Thu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Aktis Oncology, Inc.: Czibere Akos (Chief Medical Officer) sold 7,401 shares (under a trading plan set in advance) at $21.03 on 23 September 2026, $155,648https://greeksoup.ai/stocks/us/akts/insiders/us:AKTS:insider:2026-09-24:4a3dbce12eThu, 24 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Aktis Oncology, Inc.: Form 144, Akos Czibere plans to sell 25,000 shares worth $552,750 around 23 September 2026https://greeksoup.ai/stocks/us/akts/planned-sales/us:AKTS:planned-sale:2026-09-23:f2e8b4eda8Wed, 23 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Aktis Oncology, Inc.: short interest 3,252,475 shares at the 15 September 2026 settlement, 11.53 days to coverhttps://greeksoup.ai/stocks/us/akts/short-interest/us:AKTS:short-interest:2026-09-15:46d476b206Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Aktis Oncology, Inc.: short interest 3,175,040 shares at the 31 August 2026 settlement, 10.36 days to coverhttps://greeksoup.ai/stocks/us/akts/short-interest/us:AKTS:short-interest:2026-08-31:8ef8e21396Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Aktis Oncology, Inc.: short interest 3,447,126 shares at the 14 August 2026 settlement, 15.01 days to coverhttps://greeksoup.ai/stocks/us/akts/short-interest/us:AKTS:short-interest:2026-08-14:3d86254282Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Aktis Oncology, Inc. Q2 FY2025 results: revenue $2 million, net income -$18 millionhttps://greeksoup.ai/stocks/us/akts/results/fy2025-q2/us:AKTS:result:2026-08-13:3bf280b435Thu, 13 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Aktis Oncology, Inc. Q2 FY2026 results: revenue $3 million, net income -$24 millionhttps://greeksoup.ai/stocks/us/akts/results/fy2026-q2/us:AKTS:result:2026-08-13:c165153305Thu, 13 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Aktis Oncology, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/akts/filings/us:AKTS:filing:2026-08-13:808b22c254Thu, 13 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Aktis Oncology, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/akts/filings/us:AKTS:filing:2026-08-13:73a7d8174cThu, 13 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>